Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:59 PM
Ignite Modification Date:
2025-12-24 @ 5:59 PM
NCT ID:
NCT01560468
Eligibility Criteria:
Inclusion Criteria:
* Age 18-72
* Patients accepted onto waiting list for liver transplantation for HCV related liver disease and receiving a deceased donor liver allograft
* HCV RNA (+) at time of listing for transplantation. All HCV genotypes will be eligible
* Patients with HCC and those receiving hepatitis B core (+) donor livers will be eligible
* Standard immunosuppression protocol with tacrolimus, corticosteroid taper, and mycophenolate mofetil
Exclusion Criteria:
* Viral co-infection (HBV/HIV)
* Receipt of a HCV (+) donor allograft
* Patients undergoing retransplantation for recurrent HCV
* Multivisceral transplantation
* Patients receiving anti-viral therapy at the time of LT
* Live donor liver transplantation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
72 Years
Study:
NCT01560468
Study Brief:
Protocol Section:
NCT01560468